KATEKAT🐯
@katlovinglondon
I prefer to describe myself as delightfully difficult and it would just be easier if you agreed.⛱Librarian📚
ID: 47969725
17-06-2009 14:04:27
277,277K Tweet
57,57K Takipçi
147 Takip Edilen
Hank Green You’ve got this, Hank! The entire Mythical Crew’s wishing you the best 🧡
Johnson & Johnson (@JNJGlobalHealth) is unjustly extending a patent on a life-saving tuberculosis drug. Today's the day for them to realize denying MDR-TB patients treatment is not worth the harm they're causing to core brands like Tylenol and Neutrogena. youtube.com/watch?v=tMhgw5…
Tell Johnson & Johnson their attempts to evergreen the patent on the life-saving tuberculosis drug bedaquiline is unjust and a violation of their corporate credo: secure.ethicspoint.com/domain/media/e… And then tell the world that Johnson & Johnson is denying MILLIONS access to life-saving TB treatment.
!!!!!!!!!!!!! Johnson & Johnson, THANK YOU for choosing #PatientsNotPatents. Takes real guts to live up to your credo. Generic bedaquiline WILL BE AVAILABLE in almost every country with a high tuberculosis burden. I am so happy and grateful to the Stop TB Partnership, J&J, and especially
I keep crying out of nowhere. What a good day to support MSF International, Partners In Health, and all the global health orgs and activists who've been fighting for tuberculosis treatment access for decades. These people are my heroes, and today I'll be making donations in honor of TB survivors around the
Grateful to 1. Philip DeFranco 👊🏻 covers Johnson & Johnson's bedaquline story for his six million subscribers: youtu.be/KaVH4pvg9A0?t=… 2. Forbes, which seems to know more about J&J's decision than they have publicly acknowledged (just release a statement, J&J! It's easy! I'll write it for you!):